Co-Administration of Naringenin with Isoproterenol Alters Cardio-Hepatic Bioactivity in Experimental Animal Models
DOI:
https://doi.org/10.14738/aivp.1301.15977Keywords:
Isoproterenol, Troponin, Naringenin, Creatine kinase, liver enzymes, heartAbstract
Isoproterenol is a beta-1 adrenergic agonist that has over time been used in the management of cardiovascular cases. Above optimal dosage, it may lead to altered liver function and cardiac activity shown by variations in heart and liver biomarkers. This study aimed at investigating the effect of co-administration of isoproterenol and naringenin on cardio-hepato activity and when administered at separate treatment periods. Female Wistar rats were randomly divided into four groups of five rats. Group A (Control) received normal saline, group B received 18mg/kg body weight of Isoproterenol in saline (given subcutaneously, for one week), Group C received 18mg/kg of isoproterenol and naringenin (40mg/kg orally), Group D received Isoproterenol (18mg/kg) for one week and supplemented with naringenin for two weeks. Treatment lasted for 21days. Blood samples were collected for biochemical analyses, heart and liver were collected for histological analyses. Plasma Creatine kinase, Troponin, Lactate dehydrogenase, Malondealdehyde, liver enzymes, all increased in isoproterenol administration alone; dropped with co-treatment with naringenin except for ISO+NRG, but increased in activity at 1week isoproterenol treatment and then followed by two weeks naringenin treatment. Histological alterations were prominent in heart and liver of rats in all treatment groups showing moderate aggregate of myocardial inflammation with loss of cardiac tissues and also infiltration of inflammatory hepatic cells with periductal fibrosis. This results suggest that co-administration of isoproterenol with naringenin has in vivo efficacy and has the potential to improve cardiac-hepatic function, but may fail to ameliorate tissue injury at separate treatment periods.
References
Takaki MCardiac mechanoenergetics for understanding isoproterenol-induced rat heart failure. Pathophysiology, .2012, vol 19, issue 3 page 163-170
Rothert MP, Kokshoorn EJM, Kenniphaas JM, Mauve I, Laarse AIsoproterenol induced cytotoxicity in neonatal rat heart cell cultures is mediated by free radical formation. J Mol Cell Cardiol. 1989, 21:1285–1291. URL: http://dx.doi.org/10.14738/aivp.1301.15977 423
Priscilla, D. H., & Prince, P. S. M. Cardioprotective effect of gallic acid on cardiac troponin-T, cardiac marker enzymes, lipid peroxidation products and antioxidants in experimentally induced myocardial infarction in Wistar rats. Chemico-biological interactions, 2009; 179(2-3), 118-124.
Cassidy W.M, Reynolds T.B. Serum LDH in differential diagnosis of acute hepatocellular injury. J. Clin. Gastroenterology.;1994; 9: 118-121 DOI:10.1097/00004836-1994 09000-00008
Biazi GR, Frasson IG, Miksza DR, de Morais H, de Fatima Silva F, Bertolini GL, de Souza HM. Decreased hepatic response to glucagon, adrenergic agonists, and cAMP in glycogenolysis, gluconeogenesis, and glycolysis in tumor-bearing rats. J Cell Biochem. 2018; (9):7300-7309.
Bloom, S., Cancilla, P.A. Myocytolysis and mitochondrial calcification in rat myocardium after low doses of isoproterenol. The American Journal of Pathology. 1969;54(3):373–391.
Todd GL, Cullan GE, Cullan GM. Isoproterenol induced myocardial necrosis and membrane permeability alterations in the isolated perfused rabbit heart. Exp Mol Pathol 1980; 33:43–54.
Thygesen K, Alpert JS, White HD, Allan, S. J, Fred S. A, Marcello G. Hugo AK, Kristin N. Universal definition of myocardial infarction. Eur Heart Journal; 2007; 116:2634-2653.
Anderson JL, Adams CD, Antman EM, et al. ACC/AHA. Guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients with Unstable Angina/ Non-ST-Elevation Myocardial Infarction). Circulation. 2007;116:e148-e304.
Nie, Y. C., Wu, H., Li, P. B., Luo, Y. L., Long, K., Xie, L. M., ... & Su, W. W. Anti-inflammatory effects of naringin in chronic pulmonary neutrophilic inflammation in cigarette smoke-exposed rats. Journal of medicinal food, 2012 15(10), 894-900.
Mahmoud, M., Hamdan, D., Wink, M., & El-Shazly, A. Naringin and rutin prevent galactosamine induced hepatic injury in rats via attenuation of the inflammatory cascade and oxidative stress. European Scientific Journal, 2013; 9(30).
Mbaveng, A. T., Zhao, Q., & Kuete, V. Harmful and protective effects of phenolic compounds from African medicinal plants. In Toxicological Survey of African Medicinal Plants. 2014 (pp. 577-609).
Zobeiri, M., Belwal, T., Parvizi, F., Naseri, R., Farzaei, M. H., Nabavi, S. F., & Nabavi, S. M. Naringenin and its nano-formulations for fatty liver: cellular modes of action and clinical perspective. Current pharmaceutical biotechnology, 2018; 19(3), 196-205.
Rani, N., Bharti, S., Krishnamurthy, B., Bhatia, J., Sharma, C. Pharmacological properties and therapeutic potential of naringenin: a citrus flavonoid of pharmaceutical promise. Current Pharmaceutical Design, 2016; 22(28), 4341–4359.
Alam, M. A., Subhan, N., Rahman, M. M., Uddin, S. J., Reza, H. M., & Sarker, S. D. Effect of citrus flavonoids, naringin and naringenin, on metabolic syndrome and their mechanisms of action. Advances in Nutrition, 2014; 5(4), 404-417.
Bergmeyer H. U. Bernt E. Glutamate-oxaloacetate transaminase. Colorimetric determination with with 2,4-dinitrophenyl-hydrazine. In Methods of enzymatic analysis, 837 Edited by H.U: Bergmeyer. 1965; Academic Press, New York.
Bergmeyer H. U. Bernt E. Hess B. 1965 Lactic dehydrogenase. In Methods of enzymatic analysis, 736 Edited by H.U. Bergmeyer. Academic Press, New York. Nkanu, E. E. (2025). Co-Administration of Naringenin with Isoproterenol Alters Cardio-Hepatic Bioactivity in Experimental Animal Models. European
Jean CD, Maryse T, Marie JF. Plasma malondialdehyde levels during myocardial infarction. Clinica Chimica Acta 1983;129(3):319-322.
Onanuga, I., Ibrahim, R., Amin, A., Akinola, O., Omotoso, G., Ogundele, M., & Tagoe, C. Evaluation of the effects of ascorbic acid on azathioprine-induced alteration in the testes of adult Wistar rats. International Journal of Biological and Chemical Sciences, 2014, 8(2), 426. https://doi.org/10.4314/ijbcs.v8i2.2
Singal, P. Potential oxidative pathways of catecholamines in the formation of lipid peroxides and genesis of heart disease. Adv. Exp. Med. Biol. 1980, 191, 421–427.
Kondo, T.; Ogawa, Y.; Sugiyama, S.; Ito, T.; Satake, T.; Ozawa, T. Mechanism of isoproterenol induced myocardial damage. Cardiovasc. Res. 1987, 21, 248–254.
Ramakrishna, K.; Krishnamurthy, S. Indole-3-carbinol ameliorated the isoproterenol-induced myocardial infarction via multimodal mechanisms in Wistar rats. Nat. Prod. Res. 2022, 1–6.
Wong, Z.W.; Thanikachalam, P.V.; Ramamurthy, S. Molecular understanding of the protective role of natural products on isoproterenol-induced myocardial infarction: A review. Biomed. Pharmacother. 2017, 94, 1145–1166.
Upaganlawar, A.; Gandhi, H.; Balaraman, R. Isoproterenol induced myocardial infarction: Protective role of natural products. J. Pharmacol. Toxicol. 2011, 6, 1–17.
Von Harsdorf, R.; Li, P.F.; Dietz, R. Signaling pathways in reactive oxygen species-induced cardiomyocyte apoptosis. Circulation 1999, 99, 2934–2941.
Mann JM, Peirre Louis M, Kragel PJ, Kragel AH, Roberts WC. Cardiac consequences of massive acetaminophen overdose. Am J Cardiol; 1989; 63: 1018– 1021
Larson AM, Fontana RJ, Davern TJ, Polson J, Lalani EK, Hynan LS. Acetaminophen induced acute liver failure: Results of a United States multicenter, prospective study. Hepatology; 2005; 42: 1367– 1372.
Subburaman, S., K. Ganesan and M. Ramachandran. Protective role of naringenin against doxorubicininduced cardiotoxicity in a rat model: Histopathology and mRNA expression profile studies. J. Environ. Pathol., Toxicol. Oncol.,2014; 33: 363-376.
Heba M. Obeidat, Osama Y. Althunibat, Manal A. Alfwuaires, Saleem H. Aladaileh, Abdulmohsen I. Algefare, Afaf F. Almuqati, Fawaz Alasmari, Hammad Khalifeh Aldal’in, Abdulkareem A. Alanezi, Bader Alsuwayt and Mohammad H. Abukhalil. Cardioprotective Effect of Taxifolin against Isoproterenol-Induced Cardiac Injury through Decreasing Oxidative Stress, Inflammation, and Cell Death, and Activating Nrf2/HO-1 in Mice. Biomolecules 2022, 12(11), 1546; https://doi.org/10.3390/biom12111546
Cullan GM..Isoproterenol induced myocardial necrosis and membrane permeability alterations in the isolated perfused rabbit heart. Exp Mol Pathol;1980; 33:43–54
Shanmugam, G.; Challa, A.K.; Devarajan, A.; Athmanathan, B.; Litovsky, S.H.; Krishnamurthy, P.; Davidson, C.J.; Rajasekaran, N.S. Exercise mediated Nrf2 signaling protects the myocardium from isoproterenolinduced pathological remodeling. Front. Cardiovasc. Med. 2019, 6, 68.
Velusamy, P.; Mohan, T.; Ravi, D.B.; Kishore Kumar, S.; Srinivasan, A.; Chakrapani, L.N.; Singh, A.; Varadharaj, S.; Kalaiselvi, P. Targeting the Nrf2/ARE signalling pathway to mitigate isoproterenol-induced cardiac hypertrophy: Plausible role of hesperetin in redox homeostasis. Oxid. Med. Cell. Longev. 2020, 2020, 9568278.
Abdelzaher, W.Y.; Ahmed, S.M.; Welson, N.N.; Alsharif, K.F.; Batiha, G.E.-S.; Labib, D.A.A. Dapsone ameliorates isoproterenol-induced myocardial infarction via Nrf2/HO-1; TLR4/TNF-α signaling pathways and the suppression of oxidative stress, inflammation, and apoptosis in rats. Front. Pharmacol. 2021, 12, 669679. [Google Scholar] [CrossRef]
Abukhalil, M.H.; Hussein, O.E.; Aladaileh, S.H.; Althunibat, O.Y.; Al-Amarat, W.; Saghir, S.A.; Alfwuaires, M.A.; Algefare, A.I.; Alanazi, K.M.; Al-Swailmi, F.K. Visnagin prevents isoproterenol-induced myocardial injury by attenuating oxidative stress and inflammation and upregulating Nrf2 signaling in rats. J. Biochem. Mol. Toxicol. 2021, 35, e22906.
Althunibat, O.Y.; Abduh, M.S.; Abukhalil, M.H.; Aladaileh, S.H.; Hanieh, H.; Mahmoud, A.M. Umbelliferone prevents isoproterenol-induced myocardial injury by upregulating Nrf2/HO- [39]. signaling, and attenuating oxidative stress, inflammation, and cell death in rats. Biomed. Pharmacother. 2022, 149, 112900.
Chtourou, Y., Aouey, B., Kebieche, M., & Fetoui, H. Protective role of naringin against cisplatin induced oxidative stress, inflammatory response and apoptosis in rat striatum via suppressing ROS-mediated NF-κB and P53 signaling pathways. Chemico-biological interactions, 2015;239, 76-86.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Etah E. Nkanu
This work is licensed under a Creative Commons Attribution 4.0 International License.
